Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -2.16 | -23.05 |
| PEG Ratio (TTM) | 0.04 | 15.47 |
| P/S Ratio (TTM) | 2.15 | 49.46 |
| P/B Ratio (TTM) | 0.73 | 18.87 |
| P/FCF Ratio (TTM) | -1.85 | -3.27 |
| Price to 5YR AVG Earnings Ratio | -2.19 | -3.55 |
| Price to 5YR AVG FCF Ratio | -3.02 | -9.37 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -29.12% | -5.14% |
| ROE (TTM) | -31.11% | 16.69% |
| Net Profit Margin (TTM) | -99.76% | -1,583.93% |
| ROIC 5YR AVG | -2,057.26% | 15.15% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -81.96% | -57.78% | -64.18% |
| Revenue | 153.79% | 1,843.21% | 1,420.60% |
| Net Income | -80.94% | -95.65% | -87.41% |
| Cash Flow | -48.68% | -429.75% | -8,155.79% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 7.27 | 6.13 |
| Quick Ratio (TTM) | 7.27 | 5.85 |
| D/E Ratio (TTM) | 0.01 | -15.81 |
| Interest Coverage (TTM) | -25.42 | -1.57 |
| Piotroski F-Score | 2 | 5 |
| Altman Z-Score | 0.87 | 14.12 |
| LTL to 5YR AVG FCF | -0.02 | 0.17 |
| Shares Outstanding Growth 5YR AVG | 29.32% | 123.44% |